BACKGROUND: The survey was conducted to assess attitudes and patterns of health care providers (HCPs) prescribing extended regimen oral contraceptives (OCs). STUDY DESIGN: A prospective, anonymous, written survey that assessed attitudes and prescribed preferences of extended-cycle OCs was distributed at six educational conferences. RESULTS: An estimated 90% of the conference attendees participated in the survey. Of the 799 HCPs surveyed, 92% have recommended extended-cycle regimens with ob/gyn practitioners most likely to recommend their use (p<.05). The most commonly prescribed extended regimen remains an 84-day active pill cycle followed by a 7-day hormone-free interval (49%). The majority of HCPs (73.5%) continue to prescribe OCs which induce monthly withdrawal bleeds as their most common regimen. CONCLUSION: While HCPs appear to be recommending extended OC regimens more often, monthly cyclic regimens are the most commonly prescribed.
BACKGROUND: The survey was conducted to assess attitudes and patterns of health care providers (HCPs) prescribing extended regimen oral contraceptives (OCs). STUDY DESIGN: A prospective, anonymous, written survey that assessed attitudes and prescribed preferences of extended-cycle OCs was distributed at six educational conferences. RESULTS: An estimated 90% of the conference attendees participated in the survey. Of the 799 HCPs surveyed, 92% have recommended extended-cycle regimens with ob/gyn practitioners most likely to recommend their use (p<.05). The most commonly prescribed extended regimen remains an 84-day active pill cycle followed by a 7-day hormone-free interval (49%). The majority of HCPs (73.5%) continue to prescribe OCs which induce monthly withdrawal bleeds as their most common regimen. CONCLUSION: While HCPs appear to be recommending extended OC regimens more often, monthly cyclic regimens are the most commonly prescribed.
Authors: Rossella E Nappi; Iñaki Lete; Lulu K Lee; Natalia M Flores; Marie-Christine Micheletti; Boxiong Tang Journal: BMC Womens Health Date: 2018-01-18 Impact factor: 2.809